Last week, CPhI ran a series of webinars providing expert insight and analysis on how pharma is responding to the COVID-19 pandemic in several key areas.
The five webinars offered quality content from industry leaders, focusing on important, cutting-edge topics such as the industry’s response to the COVID-19 pandemic, and the impact of the crisis on global supply chains, drug manufacturing, discovery and development.
If you missed any of the webinars, full recordings are available here.
Webinar 1: Response of Pharma to the COVID-19 Pandemic
Date: Monday, May 04, 2020
In our first webinar, we hear views and insights from senior consultants at Informa Pharma Intelligence, Duncan Emerton and Daniel Chancellor, alongside Pfizer CentreOne's Contract Manufacturing Business Leader, Tom Wilson on Pharma's ongoing response to the ongoing coronavirus pandemic.
Webinar 2: Drug Repurposing Trends – a CDMO perspective
Date: Tuesday, May 05, 2020
In this webinar, Anil Kane, Executive Director, Global Head of Technical & Scientific Affairs at Patheon, part of Thermo Fisher Scientific offers a CDMO’s perspective on the latest trends on the low-risk, cost effective drug repurposing strategy to redefine off-patent generics, clinical, shelved drugs or combination drugs to treat different indications and bring them faster to market.
Webinar 3: Managing the Changing Landscape: Building a Flexible, Challenge Resistant and Patient-Centric Clinical Supply Chain
Date: Wednesday, May 06, 2020
During this, the third in our webinar series, we hear from Nicole Gray and Stephen Flaherty, Strategic Supply Solutions at Catalent Pharma Solutions who explore strategies such as alternative supply models to improve supply chain efficiency, reduce risk and respond to local, regional and global challenges during this unprecedented global crisis.
Webinar 4: COVID-19: Impact on Cell and Gene Manufacturing
Date: Thursday, May 07, 2020
Webinar 5: Impact of COVID-19: AI and Machine Learning Solutions
Date: Friday, May 08, 2020
Rounding off our series of webinars, Dr. Yugal Sharma, Senior Director at CAS and Aurelio Arias, Engagement Manager, European Thought Leadership at IQVIA join forces to deliver the analysts’ view on how to optimise artificial intelligence and machine learning for predictive analytics, clinical trials and drug discovery.